Arthritis Advisory Committee
November 16th 2010, , from 8:00 a.m. to 5:00 p.m
belimumab, proposed trade name BENLYSTA - Sponsored by Human Genome Sciences
Agenda: On November 16, 2010, the committee will discuss biologic license application 125370, belimumab, proposed trade name BENLYSTA, sponsored by Human Genome Sciences, for the proposed indication of reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment